Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 135 News Items found Meet the 2026 Graduates of the Gerstner Sloan Kettering Graduate School Monday, May 11, 2026 Fifteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 13, 2026, as part of Memorial Sloan Kettering’s 47th annual academic convocation. Targeted Therapy Shows Promising Results Against Rare Soft Tissue Sarcoma Sunday, May 31, 2026 A clinical trial led by doctors from MSK has found that abemaciclib — a drug already approved for certain breast cancers — can significantly slow the growth of dedifferentiated liposarcoma, a rare, aggressive soft tissue cancer. Meet the 2025 Graduates of the Gerstner Sloan Kettering Graduate School Monday, May 12, 2025 Fourteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 14, 2025, as part of Memorial Sloan Kettering’s 46th annual academic convocation. New Facility Eases Patient Experience and Promotes Collaborative Treatment and Research Thursday, July 1, 2010 On June 7 when Memorial Sloan Kettering opened a facility housing the novel Center for Image-Guided Interventions, a suite of endoscopy rooms, and new operating rooms for the Surgical Day Hospital. Feature Outsmarting Sarcoma: How MSK’s Experts Are Advancing Treatment and Research Progress Tuesday, November 20, 2018 Spend a day with the expert team in MSK's world-renowned sarcoma service. Pagination First page « First Previous page ‹ Previous … Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Current page 14 Next page Next › Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment